北大医药
(000788)
| 流通市值：33.02亿 | | | 总市值：33.02亿 |
| 流通股本：5.96亿 | | | 总股本：5.96亿 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 652,418,430.88 | 447,110,790.57 | 215,174,005.41 | 1,482,371,745.21 |
| 营业收入 | 652,418,430.88 | 447,110,790.57 | 215,174,005.41 | 1,482,371,745.21 |
| 二、营业总成本 | 557,547,799.87 | 376,536,216.85 | 187,513,185.93 | 1,324,838,103.56 |
| 营业成本 | 429,766,585.83 | 287,793,031.18 | 142,377,161.01 | 1,066,813,617.67 |
| 税金及附加 | 4,952,116.35 | 3,646,293.77 | 1,677,550.74 | 8,839,884.97 |
| 销售费用 | 48,374,333.54 | 34,154,799.97 | 16,976,227.13 | 115,907,882.26 |
| 管理费用 | 63,929,916.57 | 44,259,929.48 | 22,917,212.77 | 109,539,749.88 |
| 研发费用 | 15,219,388.22 | 9,963,009.85 | 4,836,976.91 | 26,855,927.91 |
| 财务费用 | -4,694,540.64 | -3,280,847.4 | -1,271,942.63 | -3,118,959.13 |
| 其中:利息费用 | 1,764,592.54 | 1,047,111.86 | 604,169.44 | 2,379,112.33 |
| 其中:利息收入 | 6,571,094.36 | 4,409,132.1 | 1,938,026.78 | 5,641,373.11 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 1,213,230.59 | 40,445.07 | 197,532.22 | - |
| 加:投资收益 | 14,363,307.95 | 14,363,271.73 | 1,989,086.49 | 6,891,785.09 |
| 资产处置收益 | -9,644.12 | -24,269.75 | -24,269.75 | 29,633.81 |
| 资产减值损失(新) | -28,013,016 | -20,063,535.94 | - | -37,476,062.15 |
| 信用减值损失(新) | 1,563,364.16 | -117,124.99 | 184,380.23 | 11,026,265.48 |
| 其他收益 | 3,639,003.99 | 2,047,252.59 | 1,247,255.06 | 3,857,734.76 |
| 四、营业利润 | 87,626,877.58 | 66,820,612.43 | 31,254,803.73 | 141,862,998.64 |
| 加:营业外收入 | 1,500,228.85 | 348,557.41 | 80,366.13 | 5,044,386.43 |
| 减:营业外支出 | 89,259.14 | 68,708.16 | 24,383.02 | 44,241,248.56 |
| 五、利润总额 | 89,037,847.29 | 67,100,461.68 | 31,310,786.84 | 102,666,136.51 |
| 减:所得税费用 | 15,223,178.84 | 11,429,647.93 | 4,314,496.93 | 19,783,178.72 |
| 六、净利润 | 73,814,668.45 | 55,670,813.75 | 26,996,289.91 | 82,882,957.79 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 73,814,668.45 | 55,670,813.75 | 26,996,289.91 | 82,882,957.79 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 73,814,668.45 | 55,670,813.75 | 26,996,289.91 | 82,882,957.79 |
| 扣除非经常损益后的净利润 | 58,258,416.2 | 43,323,842.59 | 26,495,493.05 | 100,844,196.13 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.12 | 0.09 | 0.05 | 0.14 |
| (二)稀释每股收益 | 0.12 | 0.09 | 0.05 | 0.14 |
| 九、综合收益总额 | 73,814,668.45 | 55,670,813.75 | 26,996,289.91 | 82,882,957.79 |
| 归属于母公司股东的综合收益总额 | 73,814,668.45 | 55,670,813.75 | 26,996,289.91 | 82,882,957.79 |
| 公告日期 | 2026-10-27 | 2026-08-25 | 2026-04-28 | 2026-04-28 |
| 审计意见(境内) | | | | 标准无保留意见 |